Inside Innovation

An ultrapotent, second-generation COVID-19 vaccine candidate developed by the University of Washington Medicine’s Institute for Protein Design and South Korea-based SK bioscience received $173.4 million

Spokane-based Jubilant HollisterStier announced a $92 million expansion plan to its existing manufacturing lines, which will allow the company to increase capacity by 50%. The

Eliem Therapeutics raised $60 million in a Series B funding round to advance its pipeline of clinical and preclinical drugs, following closely on the heel

Seattle has long been known as a tech hub – but now, it’s poised for a life science boom. With lab space increasingly hard to

Following a banner year for Sana Biotechnology, which saw the company bring in one of the largest IPOs in biotech history, CEO Steve Harr is

Creative Destruction Lab, a nonprofit that runs nine startup accelerators across the world, is opening a new outpost in Seattle. The 9-month program, set to